Evidence map›Paper›PMID 21878674›Full record

ArticleBlood2011

Sox4 cooperates with PU.1 haploinsufficiency in murine myeloid leukemia.

Georg Aue, Yang Du, Susan M Cleveland, Stephen B Smith, Utpal P Davé, Delong Liu, Marc A Weniger, Jean Yves Metais, Nancy A Jenkins, Neal G Copeland and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Georg AueNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Yang Du
Susan M Cleveland
Stephen B Smith
Utpal P Davé
Delong Liu
Marc A Weniger
Jean Yves Metais
Nancy A Jenkins
Neal G Copeland
Cynthia E Dunbar
National Heart Lung and Blood Institute · USVanderbilt University Medical Center · USInstitute of Molecular and Cell Biology · SGNational Institutes of Health · USUniformed Services University of the Health Sciences · US

Funding

Optimization of gene transfer safety and efficacy focusing on the NHP modelZIAHL002339 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI DUNBAR, CYNTHIA E · 2009 to 2025
$26.8M
MULTIDISCIPLINARY BASIC RESEARCH TRAINING IN CANCERT32CA009592 · NCI · VANDERBILT UNIVERSITY · PI Justin M Balko, Julie A Rhoades (Sterling) · 1987 to 2026
$10.4M
Pathogenesis of SCID-X Gene Therapy - Induced LeukemiasK08HL089403 · NHLBI · VANDERBILT UNIVERSITY · PI DAVE, UTPAL P · 2007 to 2011
$633k
Intramural NIH HHSNCI NIH HHS T32 CA009592NHLBI NIH HHS 1K08HL089403NHLBI NIH HHS K08 HL089403
6 · The paper itself

Abstract

Cooperation of multiple mutations is thought to be required for cancer development. In previous studies, murine myeloid leukemias induced by transducing wild-type bone marrow progenitors with a SRY sex determining region Y-box 4 (Sox4)-expressing retrovirus frequently carried proviral insertions at Sfpi1, decreasing its mRNA levels, suggesting that reduced Sfpi1 expression cooperates with Sox4 in myeloid leukemia induction. In support of this hypothesis, we show here that mice receiving Sox4 virus-infected Sfpi1(ko/+) bone marrow progenitors developed myeloid leukemia with increased penetrance and shortened latency. Interestingly, Sox4 expression further decreased Sfpi1 transcription. Ectopic SOX4 expression reduced endogenous PU.1 mRNA levels in HL60 promyelocytes, and decreased Sfpi1 mRNA levels were also observed in the spleens of leukemic and preleukemic mice receiving Sox4 virus-infected wild-type bone marrow cells. In addition, Sox4 protein bound to a critical upstream regulatory element of Sfpi1 in ChIP assays. Such cooperation probably occurs in de novo human acute myeloid leukemias, as an analysis of 285 acute myeloid leukemia patient samples found a significant negative correlation between SOX4 and PU.1 expression. Our results establish a novel cooperation between Sox4 and reduced Sfpi1 expression in myeloid leukemia development and suggest that SOX4 could be an important new therapeutic target in human acute myeloid leukemia.

Indexed as

AnimalsBone Marrow TransplantationCells, CulturedDisease Models, AnimalEpistasis, GeneticGene Expression ProfilingGene Expression Regulation, LeukemicHaploinsufficiencyHL-60 CellsHumansLeukemia, MyeloidMiceMice, Inbred C57BLMice, TransgenicMicroarray AnalysisProto-Oncogene ProteinsProto-Oncogene ProteinsProto-Oncogene Protein Spi-1Sox4 protein, mouseSOXC Transcription FactorsTrans-Activators

Identifiers

PMID21878674
PMCPMC3208283
OpenAlexW2051159165

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.